ISTO Technologies, Inc. Awarded Spine Technology Award for NuQu® Technology
10/25/2012 9:27:19 AM
More...
|
ISTO Technologies, Inc. Initiates Phase II Trial of NuQu®: Novel Cell-Based Therapy for the Treatment of Painful Spinal Discs
10/22/2012 9:16:09 AM
More...
|
Zimmer (ZMH) and ISTO Technologies, Inc. Announce Phase III Clinical Study to Evaluate the Effectiveness of Engineered Juvenile Cartilage to Repair Damaged Knees
2/8/2012 9:15:19 AM
More...
|
ISTO Technologies, Inc. Receives CE Mark for InQu(R) Bone Graft Substitute and Extender
10/13/2011 6:54:44 AM
More...
|
ISTO Technologies, Inc. to Present at Canaccord Genuity's Musculoskeletal Conference
2/10/2011 8:20:28 AM
More...
|
ISTO Technologies, Inc. Awarded Key Patent for NuQu(TM) Injectable Therapy for Degenerative Disc Disease
2/7/2011 7:11:09 AM
More...
|
ISTO Technologies, Inc. Completes Enrollment in Phase I NuQu Clinical Trial
10/5/2010 6:57:17 AM
More...
|
ISTO Technologies, Inc. to Present at the Jefferies 2010 Global Life Sciences Conference
6/1/2010 10:43:55 AM
More...
|
ISTO Technologies, Inc. to Present at the Canaccord Adams Musculoskeletal Conference
2/16/2010 1:06:06 PM
More...
|
ISTO Technologies, Inc. Announces FDA Approval to Initiate a Clinical Trial for a Novel Treatment for Disc Nucleus Regeneration
4/28/2009 11:12:30 AM
More...
|
|